Presentation
Connectomica is a drug discovery company that focuses on the control of the inflammatory response using the human connexin hemichannel as a target. The company has developed a new drug to treat muscular dystrophy with encouraging results.
Connectomica
Originary from: Chile
Founder: Tomás Pérez-Acle, Juan Carlos Sáez, Carlos Lagos
In Science & Business Park since: 2016
E-mail: connectomicaspa@gmail.com
Phone: +56 2 2367 2023
Website: http://www.connectomica.com
